Skip to main content
Login
institutional access

You are connecting from
Lake Geneva Public Library,
please login or register to take advantage of your institution's Ground News Plan.

Published • loading... • Updated

AZ Is Three for Three with COPD Hope Tozorakimab

Summary by Pharmaphorum
AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in COPD, setting up filings.

2 Articles

The Huntsville ItemThe Huntsville Item
Lean Left

Tozorakimab met primary endpoint in Phase III MIRANDA trial in patients with COPD

WILMINGTON, Del.--(BUSINESS WIRE)--Apr 20, 2026-

Read Full Article
PharmaphorumPharmaphorum
Center

AZ is three for three with COPD hope tozorakimab

AstraZeneca's IL-33-targeting antibody tozorakimab has hit the target in the third of three phase 3 trials in COPD, setting up filings.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 50% of the sources lean Left, 50% of the sources are Center
50% Center

Factuality Info Icon

To view factuality data please Upgrade to Premium

Ownership

Info Icon

To view ownership data please Upgrade to Vantage

Pharmaphorum broke the news on Monday, April 20, 2026.
Too Big Arrow Icon
Sources are mostly out of (0)
Blindspot Title And Logo
Stories disproportionately reported by the Left or the Right

Similar News Topics

Wilmington, Delaware icon

Wilmington, Delaware

United Kingdom icon

United Kingdom

News
Feed Dots Icon
For You
Search Icon
SearchBlindspot LogoBlindspotLocal